A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor.
Investigational New Drugs
Kelly, Ciara M CM; Shoushtari, Alexander N AN; Qin, Li-Xuan LX; D'Angelo, Sandra P SP; Dickson, Mark A MA; Gounder, Mrinal M MM; Keohan, Mary Louise ML; Mcfadyen, Chloe C; Sjoberg, Ana A; Singer, Samuel S; DeMatteo, Ronald P RP; Hwang, Sinchun S; Heinemann, M H MH; Francis, Jasmine H JH; Antonescu, Cristina R CR; Chi, Ping P; Tap, William D WD